Search research articles
Contact Us
Filters
Showing results (251-260 of 594) with videos related to
Page
of 60
Sort By:
Trials
|
April 4, 2023
A cluster randomised, 16-week, parallel-group multicentre trial to compare the effectiveness of a digital school-based cognitive behavioural resilience/wellbeing-building intervention targeting emotional and behavioural problems in vulnerable Year 4 primary school children in whole classes, to the usual school curriculum: a study protocol to the "CUES for Schools" trial
S Jolley, J Lord, D Plant, et al.
ANZ Journal of Surgery
|
April 19, 2021
Impact of ultrasound on inguinal hernia repair rates in Australia: a population-based analysis
Michael L Williams, Alexander S E McCarthy, Sally J Lord, et al.
Therapeutic Advances in Medical Oncology
|
August 4, 2022
Next-generation sequencing, should I use anti-HER2 therapy for <i>HER2</i>-amplified tumors off-label? Illustrating an extrapolation framework
Doah Cho, Sarah J Lord, John Simes, et al.
The Medical Journal of Australia
|
July 16, 2015
Australian clinical trial activity and burden of disease: an analysis of registered trials in National Health Priority Areas
Jacquelyne Lam, Sarah J Lord, Kylie E Hunter, et al.
The Journal of Pathology. Clinical Research
|
October 3, 2019
Longitudinal analysis of a secondary BRCA2 mutation using digital droplet PCR
Saira Khalique, Stephen J Pettitt, Ger Kelly, et al.
Health Policy and Planning
|
August 31, 2006
Costs and outcomes of tuberculosis control in the Russian Federation: retrospective cohort analysis
R A Atun, Y Samyshkin, F Drobniewski, et al.
Nature Reviews. Clinical Oncology
|
February 15, 2012
The potential of exploiting DNA-repair defects for optimizing lung cancer treatment
Sophie Postel-Vinay, Elsa Vanhecke, Ken A Olaussen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 23, 2021
Reporting the trajectories of adverse events over the entire treatment course in patients with recurrent platinum-sensitive ovarian cancer treated with platinum-based combination chemotherapy regimens: A graphical approach to trial adverse event reporting
Katherine E Francis, Val Gebski, Sarah J Lord, et al.
Gut
|
January 7, 2016
The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis
Oliver M Fisher, Sarah J Lord, Dan Falkenback, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 29, 2009
Historical cross-trial comparisons for competing treatments in advanced breast cancer--an empirical analysis of bias
C K Lee, S J Lord, M R Stockler, et al.
Page
of 60
Search research articles
Search
Showing results (251-260 of 594) with videos related to
Sort By:
Page
of 60
Trials
|
April 4, 2023
A cluster randomised, 16-week, parallel-group multicentre trial to compare the effectiveness of a digital school-based cognitive behavioural resilience/wellbeing-building intervention targeting emotional and behavioural problems in vulnerable Year 4 primary school children in whole classes, to the usual school curriculum: a study protocol to the "CUES for Schools" trial
S Jolley, J Lord, D Plant, et al.
ANZ Journal of Surgery
|
April 19, 2021
Impact of ultrasound on inguinal hernia repair rates in Australia: a population-based analysis
Michael L Williams, Alexander S E McCarthy, Sally J Lord, et al.
Therapeutic Advances in Medical Oncology
|
August 4, 2022
Next-generation sequencing, should I use anti-HER2 therapy for <i>HER2</i>-amplified tumors off-label? Illustrating an extrapolation framework
Doah Cho, Sarah J Lord, John Simes, et al.
The Medical Journal of Australia
|
July 16, 2015
Australian clinical trial activity and burden of disease: an analysis of registered trials in National Health Priority Areas
Jacquelyne Lam, Sarah J Lord, Kylie E Hunter, et al.
The Journal of Pathology. Clinical Research
|
October 3, 2019
Longitudinal analysis of a secondary BRCA2 mutation using digital droplet PCR
Saira Khalique, Stephen J Pettitt, Ger Kelly, et al.
Health Policy and Planning
|
August 31, 2006
Costs and outcomes of tuberculosis control in the Russian Federation: retrospective cohort analysis
R A Atun, Y Samyshkin, F Drobniewski, et al.
Nature Reviews. Clinical Oncology
|
February 15, 2012
The potential of exploiting DNA-repair defects for optimizing lung cancer treatment
Sophie Postel-Vinay, Elsa Vanhecke, Ken A Olaussen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 23, 2021
Reporting the trajectories of adverse events over the entire treatment course in patients with recurrent platinum-sensitive ovarian cancer treated with platinum-based combination chemotherapy regimens: A graphical approach to trial adverse event reporting
Katherine E Francis, Val Gebski, Sarah J Lord, et al.
Gut
|
January 7, 2016
The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis
Oliver M Fisher, Sarah J Lord, Dan Falkenback, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 29, 2009
Historical cross-trial comparisons for competing treatments in advanced breast cancer--an empirical analysis of bias
C K Lee, S J Lord, M R Stockler, et al.
Page
of 60